Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer von Bhateja, Priyanka, Chiu, Michelle, Wildey, Gary, Lipka, Mary Beth, Fu, Pingfu, Yang, Michael Chiu Lee, Ardeshir‐Larijani, Fatemeh, Sharma, Neelesh, Dowlati, Afshin

Volltext

A Supplemental Video Teaching Tool Enhances Splinting Skills von Mehrpour, Saeed Reza, Aghamirsalim, Mohamadreza, Motamedi, Seyed Mohammad Kalantar, Ardeshir Larijani, Fatemeh, Sorbi, Reza

Volltext

The relation between serum vitamin D levels and blood pressure: a population-based study von Ardeshir Larijani, Fatemeh, Kalantar Motamedi, Seyed Mohammad, Keshtkar, Abbas Ali, Khashayar, Patricia, Koleini, Zahra, Rahim, Fakher, Larijani, Bagher

Volltext

National trends in mortality attributable to metabolic risk factors in Iran von Larijani, Fatemeh Ardeshir, MD, Parsaeian, Mahboubeh, Ms, Motamedi, Seyed Mohammad Kalantar, MD, Khosravi, Ardeshir, PhD, Farzadfar, Farshad, MD, Larijani, Bagher, MD

Volltext

The MARIPOSA trials — implications for the treatment of EGFR-mutant NSCLC von Ardeshir-Larijani, Fatemeh, Ramalingam, Suresh S.

Volltext

The Trend of National and Sub-national Burden of Gastrointestinal and Liver Diseases in Iran 1990 to 2013; Study Protocol von Salimzadeh, Hamideh, Larijani, Fatemeh Ardeshir, Abedian, Shifteh, Motamedi, Seyed Mohammad Kalantar, Malekzadeh, Mohammad Masoud, Mohaghegh, Hamid, Sadeghi, Anahita, Sepanlou, Sadaf G, Delavari, Alireza, Saberi-Firoozi, Mehdi, Vahedi, Homayoun, Darzi, Ehsan Rezaei, Farzadfar, Farshad, Malekzadeh, Reza

Volltext

Utilization of circulating tumor DNA (ctDNA) analysis to detect minimal residual disease post-surgery and disease progression in metastatic thymic tumors von Ardeshir-Larijani, Fatemeh, Ravichandran, Karthik Raja, Schneider, Bryan P., Radovich, Milan, Maniar, Rohan, Masood, Ashiq, Kesler, Kenneth, Loehrer, Patrick J.

Volltext

Development of a prognostic risk model for small cell lung cancer: Identification of high-, intermediate-, and low-risk cohorts based on clinical-genomic data von Ardeshir-Larijani, Fatemeh, Wildey, Gary, Fu, Pingfu, Dowlati, Afshin

Volltext

Clinicogenomic characterization of metastatic thymic epithelial tumors von Ardeshir-Larijani, Fatemeh, Radovich, Milan, Schneider, Bryan P., Loehrer, Patrick J.

Volltext

Assessing the predictive value of ctDNA on relapse in patients with resected stage IB-IIIA NSCLC treated with adjuvant chemotherapy plus concomitant atezolizumab followed by atezol... von Ardeshir-Larijani, Fatemeh, Mohindra, Nisha Anjali, Traynor, Anne M., Malhotra, Jyoti, Shum, Elaine, Ma, Patrick C., Hanna, Nasser H.

Volltext

KMT2D Mutation Is Associated With Poor Prognosis in Non–Small-Cell Lung Cancer von Ardeshir-Larijani, Fatemeh, Bhateja, Priyanka, Lipka, Mary Beth, Sharma, Neelesh, Fu, Pingfu, Dowlati, Afshin

Volltext

Racial and ethnic differences in thymic epithelial tumors: A single-institution retrospective analysis von Wuthrich, Brice, Maniar, Rohan, Heldman, Emily, Laniak, Louis, Davis, Hannah, Ardeshir-Larijani, Fatemeh, Spittler, Aaron John, Kesler, Kenneth, Loehrer, Patrick J.

Volltext

An evaluation of cisplatin, doxorubicin, and cyclophosphamide (PAC) compared to other regimens for patients with unresectable or metastatic thymic carcinoma: A single-institution r... von Wuthrich, Brice, Maniar, Rohan, Heldman, Emily, Laniak, Louis, Davis, Hannah, Ardeshir-Larijani, Fatemeh, Spittler, Aaron John, Kesler, Kenneth, Loehrer, Patrick J.

Volltext

Trop-2 Expression and Its Impact on Survival in Thymic Epithelial Tumors: Brief Report von Ardeshir-Larijani, Fatemeh, Maniar, Rohan, Goyal, Subir, Loehrer, Patrick J, Hou, Tieying, DeBrock, Victoria, Mesa, Hector

Volltext

Phase II trial of atezolizumab (A) + carboplatin (C) + pemetrexed (P) + bevacizumab (B) in pts with stage IV non-squamous non-small cell lung cancer (NSq-NSCLC): Big Ten Cancer Res... von Ardeshir-Larijani, Fatemeh, Althouse, Sandra K., Leal, Ticiana, Feldman, Lawrence Eric, Abu Hejleh, Taher, Patel, Malini, Gentzler, Ryan D., Miller, Adam Ryan, Hanna, Nasser H.

Volltext

Frequency of NOTCH pathway mutation in primary tumor of SCLC compared to metastatic biopsies and association with better survival von Ardeshir-Larijani, Fatemeh, Wildey, Gary, Fu, Pingfu, Bhateja, Priyanka, Dowlati, Afshin

Volltext

Effects of comprehensive genomic testing in a large non-small cell cancer NSCLC cohort: Racial and survival impacts von Ardeshir-Larijani, Fatemeh, Alahmadi, Asrar, Fu, Pingfu, Wildey, Gary, Lipka, Mary Beth, Dowlati, Afshin

Volltext

Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency von Cheng, Aristine, Kashyap, Anuj, Salvator, Helene, Rosen, Lindsey B., Colby, Devon, Ardeshir-Larijani, Fatemeh, Loehrer, Patrick J., Ding, Li, Lugo Reyes, Saul O., Riminton, Sean, Ballman, Madison, Rocco, Joseph M., Marciano, Beatriz E., Freeman, Alexandra F., Browne, Sarah K., Hsu, Amy P., Zelazny, Adrian, Rajan, Arun, Sereti, Irini, Zerbe, Christa S., Lionakis, Michail S., Holland, Steven M.

Volltext

AB025. Evaluation of potential therapeutic immunohistochemical targets with experimental or FDA-approved therapies in thymic epithelial tumor microarrays von Ardeshir-Larijani, Fatemeh, Loehrer, Patrick J., Maniar, Rohan, Hou, Tieying, DeBrock, Victoria, Mesa, Hector

Volltext

Next Generation Sequencing of Advanced Non–Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival von Al-Ahmadi, Asrar, Ardeshir-Larijani, Fatemeh, Fu, Pingfu, Cao, Shufen, Lipka, Mary Beth, Dowlati, Afshin, Bruno, Debora S.

Volltext